Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Scleroderma, Localized 1 Radiation Injuries 1 Prostatic Neoplasms 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Pneumonia 1 Neurodermatitis 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lichen Planus 1 Leukemia, Hairy Cell 1 Leukemia 1 Keratoacanthoma 1 Keloid 1 Hemangioma 1 Head and Neck Neoplasms 1 Granuloma Annulare 1 Dermoid Cyst 1 Dendritic Cell Sarcoma, Interdigitating 1 Cicatrix, Hypertrophic 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

tocilizumab 1 ceftolozane, tazobactam drug combination 1 Ribavirin 1 Nebulizers and Vaporizers 1 Methylprednisolone 1 Lidocaine 1 Immunoglobulin G 1 Gelsolin 1 Etanercept 1 Disulfides 1 Calcitriol 1 Blood Specimen Collection 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pneumonia × Adrenal Cortex Hormones × Clear all

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡